Bibliografia Tumore alla Prostata

Di seguito la bibliografia dell’articolo “Tumore alla prostata: cure alternativee fitoterapia”

1. van Poppel H, Tombal B. Chemoprevention of prostate cancer with nutrients and supplements. Cancer Management and Research. 2011;3(1):91–100.
2. Rittmaster RS. Chemoprevention of prostate cancer. Acta Oncologica. 2011;50(supplement 1):127–136
3. Le Gal K, Ibrahim MX, Wiel C, Sayin VI, Akula MK, Karlsson C, Dalin MG, Akyürek LM, Lindahl P, Nilsson J, Bergo MO.
   Antioxidants can increase melanoma metastasis in mice.
   Sci Transl Med. 2015 Oct 7;7(308):308re8.
4. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
   Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD 3rd, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr.
   JAMA. 2009 Jan 7;301(1):39-51.
5. Antioxidants accelerate lung cancer progression in mice.
   Sayin VI, Ibrahim MX, Larsson E, Nilsson JA, Lindahl P, Bergo MO.
   Sci Transl Med. 2014 Jan 29;6(221):221ra15.
6. Gil MI, Tomas Barberan FA, Hess Pierce B et al.
   Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing.
   J Agric Food Chem 2000; 48: 4581–4589
7. Pantuck AJ, Leppert JT, Zomorodian N et al.
   Phase II study of pomegranate juice for men with rising prostate specific
   antigen following surgery or radiation for prostate cancer.
   Clin Cancer Res 2006; 12: 4018–4026
8. Cao Y, Cao R, Brakenhielm E.
   Antiangiogenic mechanisms of diet derived polyphenols.
   J Nutr Biochem 2002; 13: 380–390
9. Siddiqui IA, Asim M, Hafeez BB et al.
   Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer.
   FASEB J 2011; 25: 1198–1207
10. Gupta S, Hastak K, Ahmad N, Lewin JS, Mukhtar H.
    Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols.
    Proc Natl Acad Sci USA 2001; 98:10350–10355
11. Bishara T, Ramnani DM, Epstein JI. Highgrade
    prostatic intraepithelial neoplasia on
    needle biopsy: risk of cancer on repeat biopsy related to number of involved cores and
    morphologic pattern. Am J Surg Pathol 2004; 28: 629–633
12. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A.
    Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with highgrade prostate intraepithelial neoplasia: a preliminary report from a one-year proof of principle study.
    Cancer Res 2006; 66: 1234–1240
13. Brausi M, Rizzi F, Bettuzzi S.
    Chemoprevention of human prostate cancer by green tea catechins: two years later. A followup update.
    Eur Urol 2008; 54: 472–473
14. Hebert JR, Hurley TG, Olendzki BC.
    Nutritional and socioeconomic factors in relation to prostate cancer mortality: a crossnational study.
    J Natl Cancer Inst 1998; 90: 1637–1647
15. Cabrespine-Faugeras A, Bayet-Robert M, Bay JO, Chollet P, Barthomeuf C.
    Possible benefits of curcumin regimen in combination with taxane chemotherapy for hormone-refractory prostate cancer treatment.
    Nutrition and Cancer. 2010;62(2):148–153.
16. Chendil D, Ranga RS, Meigooni D, et al.
    Curcumin confers radiosensitizing effect in prostate cancer cell line PC3.
    Oncogene. 2004;23:1599–1607.
17. Tokiwa S, Sakamaki K, et al.
    Combined inhibitory effects of soy isoflavones and curcumin on the production of prostatespecific antigen.
    Prostate. 2010;70:1127–1133.
18. Levi F, Lucchini F, LaVecchia C.
    Worldwide patterns of cancer mortality 1985-89.
    Eur J Cancer Prev 1994;3:109-43.
19. Severson RK, Nomura AM, Grove JS, Stemmermann GN.
    A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii.
    Cancer Res 1989;49:1857-60.
20. Persky V, van Horn L.
    Epidemiology of soy and cancer: perspectives and directions.
    J Nutr 1995;125(3 Suppl):709S-712S.
21. Rose DP, Boyar AP, Wynder EL.
    International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption.
    Cancer 1986;58:2363-71.
22. Serra-Majem L, La Vecchia C, Ribas-Barba L, Prieto-Ramos F, Lucchini F, Ramon JM, et al. Changes in diet and mortality from selected cancers in southern Mediterranean countries, 1960—1989.
    Eur J Clin Nutr 1993;47 Suppl 1:S25-34.
23. La Vecchia C, Negri E, D’Avanzo B, Franceschi S, Boyle P.
    Dairy products and the risk of prostatic cancer.
    Oncology 1991;406:10.
24. Mettlin C, Selenskas S, Natarajan N, Huben R.
    Beta-carotene and animal fats and their relationship to prostate cancer risk. A case—control study.
    Cancer 1989;64:605-12.
25. Hebert JR, Hurley TG, Olendzki BC, Teas J, Ma Y, Hampl JS.
    Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study.
    J Natl Cancer Inst. 1998 Nov 4;90(21):1637-47.
26. Li Y, Ahmed F, Ali S, et al.
    Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to
    increased apoptosis induced by chemotherapeutic agents in human cancer cells.
    Cancer Res. 2005;65:6934–6942.
27. Raffoul JJ, Wang Y, Kucuk O, et al.
    Genistein inhibits radiationinduced activation of NFκappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest.
    BMC Cancer. 2006;6:107.
28. SinghGupta V, Zhang H, Banerjee S, et al. Radiationinduced HIF1alpha cell survival pathway is inibite by soy isoflavones in prostate cancer cells.
    Int J Cancer. 2009;124:1675–1684.
29. Lakshman M, Xu L, Ananthanarayanan V, et al.
    Dietary genistein inhibits metastasis of human prostate cancer in mice. Cancer Research. 2008;68(6):2024–2032.
30. Kumar NB, Cantor A, Allen K, et al.
    The specific role of isoflavones in reducing prostate cancer risk.
    Prostate. 2004;59:141–147.
31. Hussain M, Banerjee M, Sarkar FH, et al.
    Soy isoflavones in the treatment of prostate cancer.
    Nutr Cancer. 2003;47:111–117.
32. Giovannucci E1, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC.
    Intake of carotenoids and retinol in relation to risk of prostate cancer.
    J Natl Cancer Inst. 1995 Dec 6;87(23):1767-76.
33. Wu D1, Wu P, Zhao L, Huang L, Zhang Z, Zhao S, Huang J.NF-κB Expression and Outcomes in Solid Tumors: A Systematic Review and Meta-Analysis.
    Medicine (Baltimore). 2015 Oct;94(40):e1687.
34. Tang Y, Parmakhtiar B, Simoneau AR, et al.
    Lycopene enhances docetaxel’s effect in castrationresistant prostate cancer associated with insulinlike growth factor I receptor levels.
    Neoplasia. 2011;13:108–119.
35. Kumar NB, BestermanDahan K, Kang L, et al.
    Results of a Randomized Clinical Trial of the Action of Several Doses of Lycopene in Localized Prostate Cancer: Administration Prior to Radical Prostatectomy.
    Clin Med Urol. 2008;1:1–14.
36. Kucuk O, Sarkar FH, Sakr W, et al.
    Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy.
    Cancer Epidemiol Biomarkers Prev. 2001;10:861–868.
37. Grainger EM, Schwartz SJ, Wang S, et al.
    A combination of tomato and soy products for men with recurring prostate cancer and rising prostate specific antigen.
    Nutr Cancer. 2008;60:145–154.
38. Richman EL, Carroll PR, Chan JM.
    Vegetable and fruit intake after diagnosis and risk of prostate cancer progression.
    Int J Cancer. 2011;131(1):201–210.
39. Liu B, Mao Q, Cao M, Xie L.
    Cruciferous vegetables intake and risk of prostate cancer: a metaanalysis.
    Int J Urol. 2012;19(2):134–141.
40. He, Y. H., Friesen, M. D., Ruch, R. J. & Schut, H. A.
    Indole-3-carbinol as a chemopreventive agent in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) carcinogenesis: inhibition of PhIP-DNA adduct formation, acceleration of PhIP metabolism, and induction of cytochrome P450 in female F344 rats.
    Food Chem. Toxicol. 38:15-23 (2000).
41. Jin, L., Qi, M., Chen, D. Z., Anderson, A., Yang, G. Y., Arbeit, J. M. & Auborn, K. J.
    Indole-3-carbinol prevents cervical cancer in human papilloma virus type 16 (HPV16) transgenic mice. Cancer Res. 59:3991-3997 (1999).
42. Oganesian, A., Hendricks, J. D. & Williams, D. E.
    Long term dietary indole-3-carbinol inhibits diethylnitrosamine-initiated hepatocarcinogenesis in the infant mouse model. Cancer Lett. 118:87-94 (1997).
43. Michnovicz, J. J.
    Plant estrogens and human health. Ann. Surg. Oncol. 1996; 3:513-514.
44. Yuan, F., Chen, D. Z., Liu, K., Sepkovic, D. W., Bradlow, H. L. & Auborn, K.
    Anti-estrogenic activities of indole-3-carbinol in cervical cells: implication for prevention of cervical cancer. Anticancer Res. 1999; 19:1673-1680.
45. Verhoeven, D. T., Verhagen, H., Goldbohm, R. A., van den Brandt, P. A. & van Poppel, G.
    A review of mechanisms underlying anticarcinogenicity by brassica vegetables. Chem. Biol. Interact. 1997; 103:79-129.
46. Meng, Q., Goldberg, I. D., Rosen, E. M. & Fan, S.
    Inhibitory effects of indole-3-carbinol on invasion and migration in human breast cancer cells. Breast Cancer Res. Treat. 2000; 63:147-152.
47. Meng, Q., Qi, M., Chen, D. Z., Yuan, R., Goldberg, I. D., Rosen, E. M., Auborn, K. & Fan, S. Suppression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin complexes.
    2000; J. Mol. Med. 78:155-165.
48. Reed GA, Peterson KS, Smith HJ, et al.
    A phase I study of indole-3-carbinol in women: tolerability and effects.
    Cancer Epidemiol Biomarkers Prev. 2005;14:1953–60.
49. Naik R, Nixon S, Lopes A, Godfrey K, Hatem MH, Monaghan JM.
    A randomized phase II trial of indole-3-carbinol in the treatment of vulvar intraepithelial neoplasia.
    Int J Gynecol Cancer. 2006 Mar-Apr;16(2):786-90
50. Verhoeven DT, Goldbohm RA, van Poppel G, Verhagen H, van den Brandt PA.
    Epidemiological studies on brassica vegetables and cancer risk.
    Cancer Epidemiol Biomarkers Prev. 1996;5:733–748.
51. Fan S, Meng Q, Auborn K, et al.
    BRCA1 and BRCA2 as molecular targets for phytochemicals indole3carbinol and genistein in breast and prostate cancer cells.
    Br J Cancer. 2006;94:407–426.
52. Sarkar FH, Li Y.
    Indole3carbinol and prostate cancer.
    J Nutr. 2004;134:3493S–3498S.
53. Reed GA, Sunega JM, Sullivan DK, et al.
    Singledose pharmacokinetics and tolerability of absorptionenhanced 3,3’diindolylmethanein healthy subjects.
    Cancer Epidemiol Biomarkers Prev. 2008;17:2619–2624.
54. Heath EI, Heilbrun LK, Li J, et al.
    A phase I dose escalation study of oral BR-DIM (BioResponse 3,3’Diindolylmethane) in castrateresistant, nonmetastatic prostate cancer.
    Am J Transl Res. 2010;2:402–411.
55. Kong D, Heath E, Chen W, et al.
    Loss of let7 upregulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BRDIM.
    PLoS One. 2012;7:e33729.
56. Gil M.I, Tomàs-Barberàn F.A, Hess-Pierce B, Holcroft D.M, Kader A.A.
    Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing.
    J Agric Food Chem. 2000;48:4581–9.
57. Seeram N.P, Aviram M, Zhang Y, Henning S.M, Feng L, Dreher M, Heber D.
    Comparison of antioxidant potency of commonly consumed polyphenol-rich beverages in the United States.
    J Agric Food Chem. 2008;56:1415–22.
58. Yan Song, Jorge E. Chavarro, Yin Cao, Weiliang Qiu, Lorelei Mucci, Howard D. Sesso, Meir J. Stampfer, Edward Giovannucci, Michael Pollak, Simin Liu, and Jing Ma.
    Whole Milk Intake Is Associated with Prostate Cancer-Specific Mortality among U.S. Male Physicians1,2,3,4
    J Nutr. 2013 Feb; 143(2): 189–196.
59. Yifeng Xia, Shen Shen, and Inder M. Verma
    NF-κB, an active player in human cancers
    Cancer Immunol Res. 2014 Sep; 2(9): 823–830.
60. Donovan MJ, Osman I, Khan FM, et al.
    Androgen receptor expression is associated with prostate cancerspecific survival in castrate patients with metastatic disease.
    BJU Int. 2010;105:462–467.